Onset of nilotinib resistance in K562 and K562-Dox cells coincides with ABCB1 overexpression; ABCB1 levels decrease upon continued high dose nilotinib exposure. by Laura N. Eadie (3044079)

Neutralization of plasmas against spike-pseudotyped lentiviral particles. by Allison J. Greaney (11046384)

Infection decreases short chain phospholipids in the intestines of <i>V</i>. <i>cholerae</i>-infected flies. by Audrey S. Vanhove (4090594)

Forest–water interactions: a multilingual perspective through six historical vignettes by Delphis F. Levia (4509637)

“…For example, the French vignette focuses on the search for the hydrological role of forests, while the Russian vignette conveys an interesting example of phytoremediation and the role of evapotranspiration in decreasing malaria risk. In conjunction with a timeline for historical context, along with the identification of some seminal papers, these vignettes convey the important hydrological work of these earlier researchers, bringing some largely unrecognized work to light, thereby illuminating the historical scientific development of forest–water interactions and giving rightful credit to those pioneers who conducted the work.…”

Effect of mutations on neutralization by antibodies elicited by 2x BNT162b2 vaccination, Delta breakthrough after 2x mRNA vaccination, or primary Delta infection. by Allison J. Greaney (11046384)

Decrease of luciferase activity. by Hiroyuki Kanazawa (352289)

Decreased tumor size <i>in vivo</i> is achieved by depletion of miR-21 <i>in vitro</i>. by Sara E. Martin del Campo (683602)

γHV68-IκBαM–Infected Mice Have Decreased Splenic Latency at Later Timepoints after Intranasal Infection that Is Not Altered by Inhibiting Lytic Replication by Laurie T Krug (68237)

Ena/VASP Mislocalization Decreases the Prevalence of Fast, Persistent-Moving Smooth Cells by Catherine I Lacayo (34086)

PRISMA flow diagram. by Manik Chhabra (10822587)

Subjects:

Forest plot of comparison of saroglitazar 4mg versus control on LDL-cholesterol (mg/dL). by Manik Chhabra (10822587)

Subjects:

Treatment and outcome characteristics. by Manik Chhabra (10822587)

Subjects:

Forest plot of comparison of saroglitazar 4mg versus saroglitazar 2 mg on serum creatinine (mg/dL). by Manik Chhabra (10822587)

Subjects:

Forest plot of comparison of saroglitazar 4mg versus control on total cholesterol (mg/dL). by Manik Chhabra (10822587)

Subjects:

Forest plot of comparison of saroglitazar 4mg versus saroglitazar 2mg on LDL-cholesterol (mg/dL). by Manik Chhabra (10822587)

Subjects:

Risk of bias summary. by Manik Chhabra (10822587)

Subjects:

Risk of bias graph. by Manik Chhabra (10822587)

Subjects:

Characteristics of included studies and subjects. by Manik Chhabra (10822587)

Subjects:

Forest plot of comparison of saroglitazar 4mg versus saroglitazar 2mg on total cholesterol (mg/dL). by Manik Chhabra (10822587)

Subjects:

Table1_Eight weeks of dry dynamic breath-hold training results in larger spleen volume but does not increase haemoglobin concentration.XLSX by Kun Yang (19445)